1. Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24:621–35.
2. Abdool KQ, Abdool KSS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.
3. Grant RM, Lama JR, Anderson PL, McMahan V, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. NEJM. 2010. doi: 10.1056/NEJMoa1011205 .
4. Baeten J, Celum C, on behalf of Partners PrEP Study Team. Antiretroviral pre-exposure prophylaxis for HIV-1 prevention among heterosexual African men and women: the partners PrEP study. In: 6th international AIDS Society conference on HIV pathogenesis treatment and prevention, Rome; 2011.
5. Thigpen MC, Kebaabetswa PM, Smith DK, et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 study.In: 6th international AIDS society conference on HIV pathogenesis treatment and prevention. Rome; 2011.